Faculty profile

Pablo Rusjan

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Pablo Rusjan

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
10 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Endocannabinoid System Fatty Acid Amide Hydrolase Nicotine Positron Emission Tomography Tobacco

Latest papers

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].
EBioMedicine · 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.
EBioMedicine · 2026
MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.
Molecular psychiatry · 2026

All 13 publications

Latest funding

Investigating Endocannabinoid Activity in Brain in People with Tobacco Addiction
CIHR · 2023 · Principal investigator
$635,809
Monoamine Oxidase B (MAO-B) in Schizophrenia and Cannabis use
CIHR · 2021 · Co-investigator
$1,097,776

All 2 grants and awards

13 publications.

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Liu YK, Persaud D, Vieira EL, Braga J, Rusjan P, Miler L, Rabin JS, McCluskey T, Boileau I, Chao T, Bagby M, Narciso L, Gray LR, Vasdev N, Desmond K, Kloiber S, Warsh J, Husain MI, Smart K, Wang W, Meyer JH

EBioMedicine2026

DOI: 10.1016/j.ebiom.2026.106472 PMID: 42700719

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

EBioMedicine2026

DOI: 10.1016/j.ebiom.2026.106339 PMID: 42431745

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.

Best LM, Truong J, McCluskey T, Meyer JH, Rusjan P, Dheda SS, Pandian J, Tardelli VS, Rubin-Kahana DS, Rhind SG, Le Foll B, Warsh J, Kish SJ, Boileau I

Molecular psychiatry2026

DOI: 10.1038/s41380-025-03355-9 PMID: 41291188

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use.

Rabin RA, Farrugia J, Garani R, Mizrahi R, Rusjan P

Drug and alcohol dependence reports2025Senior author

DOI: 10.1016/j.dadr.2025.100369 PMID: 40799255

Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.

Rafiei D, De Pol M, Meyer JH, Desmond K, Ross R, Boileau I, Warsh J, Rusjan P, Vasdev N, Aloysius R, Gray L, Kolla NJ

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

DOI: 10.1038/s41386-025-02150-y PMID: 40550956

Fatty acid amide hydrolase in comorbid borderline personality disorder and major depressive disorder: Imaging with [11C]CURB PET.

De Pol MA, Rafiei D, Meyer JH, Desmond KL, McMain S, Boileau I, Warsh J, Rusjan P, Schmahl C, Vasdev N, Gray LR, Aloysius R, Kolla NJ

Neuropharmacology2025

DOI: 10.1016/j.neuropharm.2025.110436 PMID: 40158843

18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes.

Vasilevskaya A, Anastassiadis C, Thapa S, Taghdiri F, Khodadadi M, Multani N, Rusjan P, Ozzoude M, Tarazi A, Mushtaque A, Wennberg R, Houle S, Green R, Colella B, Vasdev N, Blennow K, Zetterberg H, Karikari T, Sato C, Moreno D, Rogaeva E, Mikulis D, Davis KD, Tator C, Tartaglia MC

Journal of neurology2024

DOI: 10.1007/s00415-024-12573-0 PMID: 39037476

Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

Sacher J, Zsido RG, Barth C, Zientek F, Rullmann M, Luthardt J, Patt M, Becker GA, Rusjan P, Witte AV, Regenthal R, Koushik A, Kratzsch J, Decker B, Jogschies P, Villringer A, Hesse S, Sabri O

Biological psychiatry2023

DOI: 10.1016/j.biopsych.2022.12.023 PMID: 36997451

Development of a minimally invasive simultaneous estimation method for quantifying translocator protein binding with [18F]FEPPA positron emission tomography.

Dassanayake P, Anazodo UC, Liu L, Narciso L, Iacobelli M, Hicks J, Rusjan P, Finger E, St Lawrence K

EJNMMI research2023

DOI: 10.1186/s13550-023-00950-1 PMID: 36633702

Investigating the use of plasma pTau181 in retired contact sports athletes.

Vasilevskaya A, Taghdiri F, Multani N, Ozzoude M, Tarazi A, Khodadadi M, Wennberg R, Rusjan P, Houle S, Green R, Colella B, Blennow K, Zetterberg H, Karikari T, Mikulis D, Hazrati LN, Kovacs GG, Davis KD, Tator C, Tartaglia MC

Journal of neurology2022

DOI: 10.1007/s00415-022-11223-7 PMID: 35751688

Something wrong or missing on this profile? Suggest a correction

Pablo Rusjan

Research

Latest papers

Latest funding

Corrigendum to "Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms" [EBioMedicine (2026) Jul 10: 106339].

Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms.

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use.

Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study.

Fatty acid amide hydrolase in comorbid borderline personality disorder and major depressive disorder: Imaging with [11C]CURB PET.

18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes.

Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

Development of a minimally invasive simultaneous estimation method for quantifying translocator protein binding with [18F]FEPPA positron emission tomography.

Investigating the use of plasma pTau181 in retired contact sports athletes.

Investigating Endocannabinoid Activity in Brain in People with Tobacco Addiction

Monoamine Oxidase B (MAO-B) in Schizophrenia and Cannabis use

Frequent collaborators

Isabelle Boileau

Neil Vasdev

Romina Mizrahi

Robin Green

Stefan Kloiber

Wei Wang

Kelly Smart

David Mikulis

Bernard Le Foll

Shelley McMain

Elizabeth Finger

Ruth Ross

Keith St Lawrence

Shelley McMain

Pablo Rusjan

Ekaterina Rogaeva

Lili-Naz Hazrati